CPT® Code 85576

The CPT® Code 85576 refers to a laboratory test that evaluates platelet aggregation, which is the process by which platelets clump together to form a blood clot. This test is conducted in vitro, meaning it takes place outside of a living organism, typically in a laboratory setting. During the procedure, various known platelet activators are introduced to whole blood samples to assess how well the platelets respond. These activators can include substances such as adenosine diphosphate (ADP), arachidonic acid, thrombin, epinephrine, and ristocetin. The response of the platelets to these agents is monitored to determine their aggregation ability. This test serves multiple purposes in clinical practice. It may be utilized to screen patients who are at risk for bleeding complications prior to surgical procedures, allowing healthcare providers to make informed decisions regarding patient safety. Additionally, it can be used to monitor platelet function during surgery, ensuring that the patient's hemostatic capabilities are adequate. The test is also valuable in detecting aspirin resistance, which can occur in patients who are on anti-platelet therapy but continue to experience thrombotic events. Furthermore, it aids in diagnosing and evaluating conditions associated with excessive bruising or bleeding disorders. In particular, ristocetin activator testing can assist in subtyping von Willebrand syndrome, a genetic bleeding disorder. The test requires a blood sample, which is obtained through a separately reportable venipuncture, and the whole blood is analyzed using methods such as aggregation, quantitative aggregation, or light transmission aggregometry.